Egypt Vaccines Market to 2032
Overview
The Egypt Vaccines Market is expected to reach a 87.78 USD Billion by 2032 and is projected to grow at a CAGR of 7.20% from 2025 to 2032.
Revenue, 2024 (USD Billion)
59.11
Forecast, 2032 (USD Billion)
87.78
CAGR, 2024 - 2032
7.20%
Report Coverage
Egypt
Egypt Vaccines Market 2018-2032 USD Billion
Egypt Vaccines Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 59.11 USD Billion
- Projected Market Size (2032): 87.78 USD Billion
- CAGR (2025-2032): 7.20%
Key Findings of Egypt Vaccines Market
- The Egypt Vaccines Market was valued at 59.11 USD Billion in 2024.
- The Egypt Vaccines Market is likely to grow at a CAGR of 7.20% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 53.30 USD Billion
- The fastest growing segment Influenza in Diseases Segment grew Fastest with a CAGR of 9.07% during the forecast period from 2024 to 2032.
Egypt Vaccines Market Scope
Egypt Vaccines Market Segmentation & Scope
Kind
- Required Vaccine
- Recommended Vaccines
- Routine Vaccine
Age of Administration
- Adult Vaccines
- Pediatric Vaccines
Type
- DNA Vaccines (Zika Virus)
- Toxoid Vaccines
- Inactivated Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Route of Administration
- Nasal
- Oral
- Injectable
Diseases
- Yellow Fever
- Japanese Encephalitis
- Rabies
- Varicella
- Meningococcal
- Typhoid
- Influenza
- Hepatitis
- DPT
- Measles, Mumps & Rubella
- Pneumoccocal Disease
- Others
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
End User
- Others
- Clinics
- Specialty Centres
- Hospitals
- Community Hospitals
Egypt Vaccines Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 59.11 USD Billion |
| Market Value in 2032 | 87.78 USD Billion |
| CAGR (2025-2032) | 7.20% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Kind,Age of Administration,Type,Composition,Route of Administration,Diseases,Distribution Channel,End User |
Regional Insights:
-
Leading Market (2024-2032): Egypt, leading in terms of revenue 59.11 USD Billion in 2024
- Key Country: Egypt, leading in terms of revenue with value of 59.11 USD Billion in 2024.
Segments and Scope
-
Egypt Vaccines Market to 2032, By Kind
- Routine Vaccine is the largest segment in Egypt Vaccines Market to 2032 with a revenue of 40.36 USD Billion in the year 2024.
- Recommended Vaccines is the Fastest growing segment in Egypt Vaccines Market to 2032 with a Growth rate of 6.76 % in forecast period 2025-2032.
-
Egypt Vaccines Market to 2032, By Age of Administration
- Pediatric Vaccines is the largest segment in Egypt Vaccines Market to 2032 with a revenue of 37.13 USD Billion in the year 2024.
- Adult Vaccines is the Fastest growing segment in Egypt Vaccines Market to 2032 with a Growth rate of 7.00 % in forecast period 2025-2032.
-
Egypt Vaccines Market to 2032, By Type
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines is the largest segment in Egypt Vaccines Market to 2032 with a revenue of 22.06 USD Billion in the year 2024.
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines is the Fastest growing segment in Egypt Vaccines Market to 2032 with a Growth rate of 7.97 % in forecast period 2025-2032.
-
Egypt Vaccines Market to 2032, By Composition
- Combination Vaccines is the largest segment in Egypt Vaccines Market to 2032 with a revenue of 46.07 USD Billion in the year 2024.
- Combination Vaccines is the Fastest growing segment in Egypt Vaccines Market to 2032 with a Growth rate of 7.47 % in forecast period 2025-2032.
-
Egypt Vaccines Market to 2032, By Route of Administration
- Injectable is the largest segment in Egypt Vaccines Market to 2032 with a revenue of 53.30 USD Billion in the year 2024.
- Injectable is the Fastest growing segment in Egypt Vaccines Market to 2032 with a Growth rate of 7.43 % in forecast period 2025-2032.
-
Egypt Vaccines Market to 2032, By Diseases
- Pneumoccocal Disease is the largest segment in Egypt Vaccines Market to 2032 with a revenue of 8.50 USD Billion in the year 2024.
- Influenza is the Fastest growing segment in Egypt Vaccines Market to 2032 with a Growth rate of 8.41 % in forecast period 2025-2032.
-
Egypt Vaccines Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in Egypt Vaccines Market to 2032 with a revenue of 45.23 USD Billion in the year 2024.
- Retail Pharmacy is the Fastest growing segment in Egypt Vaccines Market to 2032 with a Growth rate of 6.87 % in forecast period 2025-2032.
-
Egypt Vaccines Market to 2032, By End User
- Community Hospitals is the largest segment in Egypt Vaccines Market to 2032 with a revenue of 40.51 USD Billion in the year 2024.
- Specialty Centres is the Fastest growing segment in Egypt Vaccines Market to 2032 with a Growth rate of 6.97 % in forecast period 2025-2032.
Egypt Vaccines Market Company Share Analysis
Egypt Vaccines Market Geographical Sales Distribution, 2018-2032 USD Billion
Egypt Vaccines Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Egypt Vaccines Market is segmented based on Segmentation Kind,Age of Administration,Type,Composition,Route of Administration,Diseases,Distribution Channel,End User.
Egypt Vaccines Market was valued at USD 59.11(Revenue in USD Billion) in 2020.
Egypt Vaccines Market is projected to grow at a CAGR of 7.20% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the Egypt Vaccines Market, holding a largest market share of 53.30 USD Billion in 2024
Coming Soon....
Egypt Vaccines Market Scope
Egypt Vaccines Market Segmentation & Scope
Kind
- Required Vaccine
- Recommended Vaccines
- Routine Vaccine
Age of Administration
- Adult Vaccines
- Pediatric Vaccines
Type
- DNA Vaccines (Zika Virus)
- Toxoid Vaccines
- Inactivated Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Route of Administration
- Nasal
- Oral
- Injectable
Diseases
- Yellow Fever
- Japanese Encephalitis
- Rabies
- Varicella
- Meningococcal
- Typhoid
- Influenza
- Hepatitis
- DPT
- Measles, Mumps & Rubella
- Pneumoccocal Disease
- Others
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
End User
- Others
- Clinics
- Specialty Centres
- Hospitals
- Community Hospitals
Frequently Asked Questions
The Egypt Vaccines Market is segmented based on Segmentation Kind,Age of Administration,Type,Composition,Route of Administration,Diseases,Distribution Channel,End User.
Egypt Vaccines Market was valued at USD 59.11(Revenue in USD Billion) in 2020.
Egypt Vaccines Market is projected to grow at a CAGR of 7.20% during the forecast period of 2024 to 2032.
The estimated market value of the Egypt Vaccines Market for final year is USD 87.78 (USD Billion).
Egypt Vaccines Market Company Profiling
Frequently Asked Questions
The Egypt Vaccines Market is segmented based on Segmentation Kind,Age of Administration,Type,Composition,Route of Administration,Diseases,Distribution Channel,End User.
Egypt Vaccines Market was valued at USD 59.11(Revenue in USD Billion) in 2020.
Egypt Vaccines Market is projected to grow at a CAGR of 7.20% during the forecast period of 2024 to 2032.
The estimated market value of the Egypt Vaccines Market for final year is USD 87.78 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.